Immunoassays Market Size (2024 - 2029)

The immunoassay market is experiencing growth driven by the increasing demand for diagnostic solutions, particularly highlighted during the COVID-19 pandemic. The need for rapid and accurate diagnosis, alongside the development of vaccines, has bolstered the market's expansion. Technological advancements and the high sensitivity and specificity of immunoassays are key factors contributing to the market's growth, as they are effective in diagnosing asymptomatic diseases and infectious conditions. The versatility and ease of automation of immunoassays further support their widespread adoption. Additionally, the introduction of innovative products by major market players is enhancing market dynamics. However, challenges such as complex procedures and stringent regulatory requirements may pose obstacles to market growth.

Market Size of Immunoassays Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Immunoassays Market Summary
Study Period 2021 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 7.70 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Immunoassays Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Immunoassays Market Analysis

The Immunoassays Market is projected to register a CAGR of 7.7% during the forecast period.

During the COVID-19 pandemic, the need for diagnostic solutions for the accurate and rapid diagnosis of SARS-CoV-2 infection increased significantly. In particular, serological and immunological testing of infected asymptomatic and symptomatic individuals was in high demand. Though RT-PCR for the detection of COVID-19 disease was widely used there was also a great demand for immunological assays. The results provided by immunological tests play an important role in the development of the COVID-19 vaccine, which also increased the need for immunoassay testing. Furthermore, post-pandemic, immunoassays are still in demand due to their significance in the development of vaccines and the diagnosis of various diseases. For instance, according to the article published in 'SelectScience' in January 2021, the use of vaccines as immunotherapies for various disorders, such as some malignancies and Alzheimer's disease, has led to increased development of advanced immunotherapies. This has led to increased adoption of immunoassays during the testing of immunotherapies, driving market growth.

The major factors that are driving the market growth include the rising prevalence and incidence of chronic as well as infectious diseases along with the technological advancements in immunoassay instruments and the high sensitivity and specificity of the immunoassays. Immunoassays are also suitable for diagnosing asymptomatic diseases, which otherwise cannot be diagnosed. The ultrasensitive immunoassay has been proven to detect HIV and is demonstrated to detect limits of less than 1fg/ml. This high sensitivity helps to detect one virus particle per 25 μl of the sample. The versatile applications and ease of automation have made immunoassay quite popular which is supporting the market growth.

The rising number of people affected by these infectious diseases is further contributing to the market growth. According to the WHO's key facts on HIV published in July 2022, around 38.4 million people around the world were affected by HIV in 2021 with around 1.5 million new cases being registered in 2021 alone. Therefore, the rising number of infectious diseases is expected to drive market growth due to the increased adoption of immunoassays for the diagnosis of infectious diseases.

Besides, the launch of products by the key market players is also aiding in the growth of the market. For instance, in November 2021, Boditech Med launched its new automated immunoassay analyzer with a blood collection tube, including an all-in-one cartridge system, at MEDICA 2021. The immunoassay analyzer, AFIAS-10, is a unique integrated Sample-to-Answer system that can execute 10 parallel tests for each different parameter. Such progress in immune analyzers is expected to propel the growth of the market over the forecast period due to the increased adoption of parallel testing of different parameters at once.

Thus, the high sensitivity, specificity, and cost-saving nature of immunoassays are driving the growth of the immunoassays market. However, factors, such as complex assay procedures and stringent regulatory scenarios for the approval of immunoassays, may hinder market growth.

Immunoassays Industry Segmentation

As per the scope of this report, an immunoassay is a test that relies on biochemistry to measure the presence and concentration of an analyte. The analyte can be large proteins, antibodies that a person has produced as a result of an infection, or small molecules. Immunoassays are highly sensitive and specific. Their high specificity results from the use of antibodies and purified antigens as reagents. The Immunoassays Market is Segmented by Type (Radioimmunoassay, Enzyme Immunoassays, Fluoroimmnoassay, Chemiluminescence Immunoassay, Others), Application (Disease Diagnosis, Therapeutic Drug Monitoring, Drug Discovery, Clinical Chemistry, Hematology, Others), End-User (Hospitals, Pharma & Biotech Companies, Clinical Laboratories Others) and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Type
Radioimmunoassay (RIA)
Enzyme Immunoassays (EIA)
Fluoroimmnoassay (FIA)
Chemiluminescence Immunoassay (CLIA)
Others
By Application
Disease Diagnosis
Therapeutic Drug Monitoring
Drug Discovery
Clinical Chemistry
Hematology
Others
By End User
Hospitals
Pharma & Biotech Companies
Clinical Laboratories
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Immunoassays Market Size Summary

The immunoassay market is experiencing significant growth, driven by the increasing demand for diagnostic solutions and advancements in technology. The COVID-19 pandemic highlighted the importance of immunoassays for rapid and accurate diagnosis, particularly in serological testing, which contributed to the market's expansion. Post-pandemic, the relevance of immunoassays continues to rise due to their critical role in vaccine development and disease diagnosis, including chronic and infectious diseases. The high sensitivity and specificity of immunoassays, along with their ability to diagnose asymptomatic conditions, have further propelled their adoption. Technological advancements and the versatility of immunoassays, such as enzyme-linked immunosorbent assays (ELISA), have made them a popular choice in clinical settings, supporting market growth.

The market is also benefiting from the launch of innovative products by key players, which enhance the capabilities of immunoassays. These developments are supported by the increasing incidence of chronic disorders and infectious diseases, particularly in regions with well-developed healthcare infrastructure like the United States. The rising healthcare expenditures and investments in research and development by pharmaceutical companies are further fueling market expansion. Additionally, strategic collaborations and acquisitions among major players are contributing to the market's competitive landscape. Despite challenges such as complex assay procedures and regulatory hurdles, the immunoassay market is poised for continued growth, driven by its cost-effective and efficient diagnostic solutions.

Explore More

Immunoassays Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 High Sensitivity and Specificity of Immunoassays

      2. 1.2.2 Technological Advancements in Immunoassay Instruments

      3. 1.2.3 Increasing Prevalence of Chronic and Infectious Diseases

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulatory Scenario for Approval of Immunoassays

      2. 1.3.2 Complexity of Procedures

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Type

      1. 2.1.1 Radioimmunoassay (RIA)

      2. 2.1.2 Enzyme Immunoassays (EIA)

      3. 2.1.3 Fluoroimmnoassay (FIA)

      4. 2.1.4 Chemiluminescence Immunoassay (CLIA)

      5. 2.1.5 Others

    2. 2.2 By Application

      1. 2.2.1 Disease Diagnosis

      2. 2.2.2 Therapeutic Drug Monitoring

      3. 2.2.3 Drug Discovery

      4. 2.2.4 Clinical Chemistry

      5. 2.2.5 Hematology

      6. 2.2.6 Others

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Pharma & Biotech Companies

      3. 2.3.3 Clinical Laboratories

      4. 2.3.4 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Immunoassays Market Size FAQs

The Immunoassays Market is projected to register a CAGR of 7.70% during the forecast period (2024-2029)

Abbott Laboratories Inc., Becton Dickinson and Company, Danaher Corporation, Hologic Inc. and Qiagen NV are the major companies operating in the Immunoassays Market.

Immunoassay Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)